Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Expression and Localization of DDX3 in Prostate Cancer Progression and Metastasis.

Vellky JE, Ricke EA, Huang W, Ricke WA.

Am J Pathol. 2019 Jun;189(6):1256-1267. doi: 10.1016/j.ajpath.2019.02.011. Epub 2019 Mar 27.

PMID:
30926334
2.

The prognostic effect of DDX3 upregulation in distant breast cancer metastases.

Heerma van Voss MR, Schrijver WA, Ter Hoeve ND, Hoefnagel LD, Manson QF, van der Wall E, Raman V, van Diest PJ; Dutch Distant Breast Cancer Metastases Consortium.

Clin Exp Metastasis. 2017 Jan;34(1):85-92. doi: 10.1007/s10585-016-9832-8. Epub 2016 Dec 20.

4.

Investigating nucleo-cytoplasmic shuttling of the human DEAD-box helicase DDX3.

Brennan R, Haap-Hoff A, Gu L, Gautier V, Long A, Schröder M.

Eur J Cell Biol. 2018 Sep;97(7):501-511. doi: 10.1016/j.ejcb.2018.08.001. Epub 2018 Aug 4.

PMID:
30131165
5.

Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer.

Heerma van Voss MR, Vesuna F, Bol GM, Meeldijk J, Raman A, Offerhaus GJ, Buerger H, Patel AH, van der Wall E, van Diest PJ, Raman V.

Onco Targets Ther. 2017 Jul 17;10:3501-3513. doi: 10.2147/OTT.S140639. eCollection 2017.

6.

NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.

Xie M, Vesuna F, Botlagunta M, Bol GM, Irving A, Bergman Y, Hosmane RS, Kato Y, Winnard PT Jr, Raman V.

Oncotarget. 2015 Oct 6;6(30):29901-13. doi: 10.18632/oncotarget.4898.

7.

MicroRNA expression profiles in the progression of prostate cancer--from high-grade prostate intraepithelial neoplasia to metastasis.

Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sañudo A, Camara-Lopes LH, Srougi M.

Urol Oncol. 2013 Aug;31(6):796-801. doi: 10.1016/j.urolonc.2011.07.002. Epub 2011 Aug 30.

PMID:
21880514
8.

Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases.

Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra R, de Vere White RW, Ghosh PM.

Clin Cancer Res. 2009 Feb 1;15(3):788-96. doi: 10.1158/1078-0432.CCR-08-1402.

9.

Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer.

Heerma van Voss MR, Vesuna F, Trumpi K, Brilliant J, Berlinicke C, de Leng W, Kranenburg O, Offerhaus GJ, Bürger H, van der Wall E, van Diest PJ, Raman V.

Oncotarget. 2015 Sep 29;6(29):28312-26. doi: 10.18632/oncotarget.4873.

10.

DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.

Chang PC, Chi CW, Chau GY, Li FY, Tsai YH, Wu JC, Wu Lee YH.

Oncogene. 2006 Mar 30;25(14):1991-2003.

PMID:
16301996
11.

DDX3 Activates CBC-eIF3-Mediated Translation of uORF-Containing Oncogenic mRNAs to Promote Metastasis in HNSCC.

Chen HH, Yu HI, Yang MH, Tarn WY.

Cancer Res. 2018 Aug 15;78(16):4512-4523. doi: 10.1158/0008-5472.CAN-18-0282. Epub 2018 Jun 19.

PMID:
29921696
12.

DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.

Su CY, Lin TC, Lin YF, Chen MH, Lee CH, Wang HY, Lee YC, Liu YP, Chen CL, Hsiao M.

Oncotarget. 2015 Jul 30;6(21):18602-12.

13.

DEAD-box RNA helicase DDX3 connects CRM1-dependent nuclear export and translation of the HIV-1 unspliced mRNA through its N-terminal domain.

Fröhlich A, Rojas-Araya B, Pereira-Montecinos C, Dellarossa A, Toro-Ascuy D, Prades-Pérez Y, García-de-Gracia F, Garcés-Alday A, Rubilar PS, Valiente-Echeverría F, Ohlmann T, Soto-Rifo R.

Biochim Biophys Acta. 2016 May;1859(5):719-30. doi: 10.1016/j.bbagrm.2016.03.009. Epub 2016 Mar 21.

PMID:
27012366
14.

Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein.

Shih JW, Tsai TY, Chao CH, Wu Lee YH.

Oncogene. 2008 Jan 24;27(5):700-14. Epub 2007 Jul 30.

PMID:
17667941
16.
17.

RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3.

Xie M, Vesuna F, Tantravedi S, Bol GM, Heerma van Voss MR, Nugent K, Malek R, Gabrielson K, van Diest PJ, Tran PT, Raman V.

Cancer Res. 2016 Nov 1;76(21):6340-6350. Epub 2016 Sep 12.

18.

DDX3, a potential target for cancer treatment.

Bol GM, Xie M, Raman V.

Mol Cancer. 2015 Nov 5;14:188. doi: 10.1186/s12943-015-0461-7. Review.

19.

Knockdown of cellular RNA helicase DDX3 by short hairpin RNAs suppresses HIV-1 viral replication without inducing apoptosis.

Ishaq M, Hu J, Wu X, Fu Q, Yang Y, Liu Q, Guo D.

Mol Biotechnol. 2008 Jul;39(3):231-8. doi: 10.1007/s12033-008-9040-0. Epub 2008 Feb 8.

PMID:
18259889
20.

EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression.

Li S, Ma Y, Xie C, Wu Z, Kang Z, Fang Z, Su B, Guan M.

Oncotarget. 2015 Sep 8;6(26):22587-97.

Supplemental Content

Support Center